Home

Ocrelizumab

Tender information

TED EU

Madrid, Spain

Type
29
Procedure
neg-wo-call
Ref. number
299877-2024
Estimated value
309,615 EUR
CPV
33652300

Adquisición del medicamento Ocrelizumab

Show all tender information

Documents

Show all important dates